IIA
VRTX icon

ICW Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

ICW Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Sell
751
-14
-2% -$6.21K 0.13% 130
2026
Q1 		$342K Buy
765
+101
+15% +$47.1K 0.12% 132
2025
Q4 		$301K Buy
664
+32
+5% +$13.8K 0.11% 133
2025
Q3 		$247K Buy
632
+28
+5% +$11.7K 0.09% 140
2025
Q2 		$269K Buy
604
+29
+5% +$13.4K 0.11% 135
2025
Q1 		$279K Buy
575
+18
+3% +$8.39K 0.11% 134
2024
Q4 		$224K Buy
557
+3
+0.5% +$1.39K 0.09% 138
2024
Q3 		$258K Buy
+554
New +$266K 0.11% 136

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ICW Investment Advisors's VRTX Position: Q2 2026 in Review

ICW Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1.8% in Q2 2026, selling an estimated $6.21K and leaving 751 shares worth $373K. The position accounts for 0.13% of the portfolio, ranked #130.

ICW Investment Advisors first reported a position in VRTX in Q3 2024 and has held it in 8 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • ICW Investment Advisors held 751 shares of Vertex Pharmaceuticals worth $373K as of Q2 2026.
  • ICW Investment Advisors sold 14 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.21K.
  • Vertex Pharmaceuticals made up 0.13% of ICW Investment Advisors's portfolio in Q2 2026, its #130 holding.
  • ICW Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on ICW Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.